- Home
- ZYXI vs GNFT Comparison
ZYXI vs GNFT Comparison
Compare ZYXI & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- GNFT
- Stock Information
- Founded
- ZYXI 1996
- GNFT 1999
- Country
- ZYXI United States
- GNFT France
- Employees
- ZYXI N/A
- GNFT N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZYXI Health Care
- GNFT Health Care
- Exchange
- ZYXI Nasdaq
- GNFT Nasdaq
- Market Cap
- ZYXI 257.1M
- GNFT 249.0M
- IPO Year
- ZYXI N/A
- GNFT 2019
- Fundamental
- Price
- ZYXI $7.52
- GNFT $5.59
- Analyst Decision
- ZYXI Strong Buy
- GNFT Strong Buy
- Analyst Count
- ZYXI 2
- GNFT 1
- Target Price
- ZYXI $13.50
- GNFT $13.00
- AVG Volume (30 Days)
- ZYXI 95.3K
- GNFT 21.1K
- Earning Date
- ZYXI 10-24-2024
- GNFT 09-19-2024
- Dividend Yield
- ZYXI N/A
- GNFT N/A
- EPS Growth
- ZYXI N/A
- GNFT N/A
- EPS
- ZYXI 0.18
- GNFT 0.47
- Revenue
- ZYXI $193,614,000.00
- GNFT $86,225,222.00
- Revenue This Year
- ZYXI $11.68
- GNFT $155.44
- Revenue Next Year
- ZYXI $20.90
- GNFT N/A
- P/E Ratio
- ZYXI $41.49
- GNFT $11.74
- Revenue Growth
- ZYXI 9.11
- GNFT 175.45
- 52 Week Low
- ZYXI $7.04
- GNFT $2.97
- 52 Week High
- ZYXI $13.77
- GNFT $6.05
- Technical
- Relative Strength Index (RSI)
- ZYXI 42.26
- GNFT 62.71
- Support Level
- ZYXI $7.61
- GNFT $5.12
- Resistance Level
- ZYXI $7.99
- GNFT $5.84
- Average True Range (ATR)
- ZYXI 0.28
- GNFT 0.32
- MACD
- ZYXI -0.03
- GNFT 0.02
- Stochastic Oscillator
- ZYXI 11.63
- GNFT 60.94
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.